Expression of blood group genes by mesenchymal stem cells

British Journal of Haematology

Volumn 153, Issue 4, 2011, Pages 520-528

  Schäfer, Richard ^a,b   Schnaidt, Martina ^a   Klaffschenkel, Roland A ^a   Siegel, Georg ^a   Schüle, Michael ^a   Rädlein, Maria Anna ^a   Hermanutz Klein, Ursula ^a   Ayturan, Miriam ^a   Buadze, Marine ^a   Gassner, Christoph ^c   Danielyan, Lusine ^a   Kluba, Torsten ^a   Northoff, Hinnak ^a   Flegel, Willy A ^d  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Harvard University   (United States)

^c Zurich SRC   (Switzerland)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood groups; CD173; H antigen; Mesenchymal cells; Stem cell transplantation

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; BLOOD GROUP H ANTIGEN; CELL PROTEIN; DUFFY ANTIGEN RECEPTOR OF CHEMOKINE DERIVATIVE; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG; UREA TRANSPORTER TYPE B;

ADIPOCYTE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL SUBPOPULATION; CONTROLLED STUDY; DARC GENE; ERYTHROCYTE; FUT1 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; KEL GENE; MESENCHYMAL STEM CELL; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; RHCE GENE; RNA TRANSCRIPTION; SLC141A GENE;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP ANTIGENS; CELL DIFFERENTIATION; CELLS, CULTURED; DUFFY BLOOD-GROUP SYSTEM; ERYTHROCYTES; GANGLIOSIDES; HUMANS; IMMUNOPHENOTYPING; MEMBRANE TRANSPORT PROTEINS; MESENCHYMAL STEM CELLS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 79955037007     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08652.x     Document Type: Article

References (48)

1. Ball, L.M., Bernardo, M.E., Roelofs, H., Lankester, A., Cometa, A., Egeler, R.M., Locatelli, F. & Fibbe, W.E. (2007) Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood, 110, 2764-2767.
2. Beggs, K.J., Lyubimov, A., Borneman, J.N., Bartholomew, A., Moseley, A., Dodds, R., Archambault, M.P., Smith, A.K. & McIntosh, K.R. (2006) Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplantation, 15, 711-721.
3. Bieback, K., Hecker, A., Kocaomer, A., Lannert, H., Schallmoser, K., Strunk, D. & Kluter, H. (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells, 27, 2331-2341.
4. Bieback, K., Ha, V.A., Hecker, A., Grassl, M., Kinzebach, S., Solz, H., Sticht, C., Kluter, H. & Bugert, P. (2010) Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements. Tissue Engineering Part A, 16, 3467-3484.
5. Buhring, H.J., Kuci, S., Conze, T., Rathke, G., Bartolovic, K., Grunebach, F., Scherl-Mostageer, M., Brummendorf, T.H., Schweifer, N. & Lammers, R. (2004) CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and non-hematopoietic origin. Stem Cells, 22, 334-343.
6. Cao, Y., Merling, A., Karsten, U. & Schwartz-Albiez, R. (2001) The fucosylated histo-blood group antigens H type 2 (blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+ hematopoietic progenitors but absent on mature lymphocytes. Glycobiology, 11, 677-683.
7. Chan, J.L., Tang, K.C., Patel, A.P., Bonilla, L.M., Pierobon, N., Ponzio, N.M. & Rameshwar, P. (2006) Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood, 107, 4817-4824.
8. Chang, W.W., Lee, C.H., Lee, P., Lin, J., Hsu, C.W., Hung, J.T., Lin, J.J., Yu, J.C., Shao, L.E., Yu, J., Wong, C.H. & Yu, A.L. (2008) Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proceedings of the National Academy of Sciences of the United States of America, 105, 11667-11672.
9. Colter, D.C., Sekiya, I. & Prockop, D.J. (2001) Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proceedings of the National Academy of Sciences of the United States of America, 98, 7841-7845.
10. Colvin, R.B. & Smith, R.N. (2005) Antibody-mediated organ-allograft rejection. Nature Reviews Immunology, 5, 807-817.
11. Daniels, G., Castilho, L., Flegel, W.A., Fletcher, A., Garratty, G., Levene, C., Lomas-Francis, C., Moulds, J.M., Moulds, J.J., Olsson, M.L., Overbeeke, M., Poole, J., Reid, M.E., Rouger, P., van der Schoot, E., Scott, M., Sistonen, P., Smart, E., Storry, J.R., Tani, Y., Yu, L.C., Wendel, S., Westhoff, C., Yahalom, V. & Zelinski, T. (2009) International society of blood transfusion committee on terminology for red blood cell surface antigens: macao report. Vox Sanguinis, 96, 153-156.
12. Dominici, M., Hofmann, T.J. & Horwitz, E.M. (2001) Bone marrow mesenchymal cells: biological properties and clinical applications. Journal of Biological Regulators and Homeostatic Agents, 15, 28-37.
13. Flegel, W.A., Curin-Serbec, V., Delamaire, M., Donvito, B., Ikeda, H., Jorgensen, J., Kumpel, B., Le Pennec, P.Y., Pisacka, M., Tani, Y., Uchikawa, M., Wendel, S. & Wagner, F.F. (2002) Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination. Transfusion Clinique et Biologique, 9, 33-42.
14. Giesert, C., Marxer, A., Sutherland, D.R., Schuh, A.C., Kanz, L. & Buhring, H.J. (2003) Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34- hematopoietic and mesenchymal stem cell subsets. Annals of the New York Academy of Sciences, 996, 227-230.
15. Hadley, T.J. & Peiper, S.C. (1997) From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood, 89, 3077-3091.
16. Han, K.H., Croker, B.P., Clapp, W.L., Werner, D., Sahni, M., Kim, J., Kim, H.Y., Handlogten, M.E. & Weiner, I.D. (2006) Expression of the ammonia transporter, rh C glycoprotein, in normal and neoplastic human kidney. Journal of the American Society of Nephrology, 17, 2670-2679.
17. Handlogten, M.E., Hong, S.P., Zhang, L., Vander, A.W., Steinbaum, M.L., Campbell-Thompson, M. & Weiner, I.D. (2005) Expression of the ammonia transporter proteins Rh B glycoprotein and Rh C glycoprotein in the intestinal tract. American Journal of Physiology Gastrointestinal and Liver Physiology, 288, G1036-G1047.
18. Herzog, E.L., Chai, L. & Krause, D.S. (2003) Plasticity of marrow-derived stem cells. Blood, 102, 3483-3493.
19. Horwitz, E.M., Prockop, D.J., Fitzpatrick, L.A., Koo, W.W., Gordon, P.L., Neel, M., Sussman, M., Orchard, P., Marx, J.C., Pyeritz, R.E. & Brenner, M.K. (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Medicine, 5, 309-313.
20. Horwitz, E.M., Prockop, D.J., Gordon, P.L., Koo, W.W., Fitzpatrick, L.A., Neel, M.D., McCarville, M.E., Orchard, P.J., Pyeritz, R.E. & Brenner, M.K. (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood, 97, 1227-1231.
21. Huang, C.H. (1998) The human Rh50 glycoprotein gene. Structural organization and associated splicing defect resulting in Rh (null) disease. Journal of Biological Chemistry, 273, 2207-2213.
22. Ji, J.F., He, B.P., Dheen, S.T. & Tay, S.S. (2004) Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells, 22, 415-427.
23. Kern, S., Eichler, H., Stoeve, J., Kluter, H. & Bieback, K. (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24, 1294-1301.
24. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M. & Ringden, O. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363, 1439-1441.
25. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M.E., Remberger, M., Dini, G., Egeler, R.M., Bacigalupo, A., Fibbe, W. & Ringden, O. (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet, 371, 1579-1586.
26. Marini, A.M., Matassi, G., Raynal, V., Andre, B., Cartron, J.P. & Cherif-Zahar, B. (2000) The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nature Genetics, 26, 341-344.
27. Martinez, C., Hofmann, T.J., Marino, R., Dominici, M. & Horwitz, E.M. (2007) Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood, 109, 4245-4248.
28. Mouro-Chanteloup, I., D' Ambrosio, A.M., Gane, P., Le Van Kim, C., Raynal, V., Dhermy, D., Cartron, J.P. & Colin, Y. (2002) Cell-surface expression of RhD blood group polypeptide is posttranscriptionally regulated by the RhAG glycoprotein. Blood, 100, 1038-1047.
29. Muruganandan, S., Roman, A.A. & Sinal, C.J. (2009) Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cellular and Molecular Life Sciences, 66, 236-253.
30. Nauta, A.J., Westerhuis, G., Kruisselbrink, A.B., Lurvink, E.G., Willemze, R. & Fibbe, W.E. (2006) Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a non-myeloablative setting. Blood, 108, 2114-2120.
31. Phinney, D.G. & Prockop, D.J. (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views. Stem Cells, 25, 2896-2902.
32. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S. & Marshak, D.R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
33. Prichett, W.P., Patton, A.J., Field, J.A., Brun, K.A., Emery, J.G., Tan, K.B., Rieman, D.J., McClung, H.A., Nadeau, D.P., Mooney, J.L., Suva, L.J., Gowen, M. & Nuttall, M.E. (2000) Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone. Journal of Cellular Biochemistry, 76, 639-650.
34. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C. & Deliliers, G.L. (2002) Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Experimental Hematology, 30, 783-791.
35. Russo, D., Wu, X., Redman, C.M. & Lee, S. (2000) Expression of Kell blood group protein in non-erythroid tissues. Blood, 96, 340-346.
36. Satija, N.K., Singh, V.K., Verma, Y.K., Gupta, P., Sharma, S., Afrin, F., Sharma, M., Sharma, P., Tripathi, R.P. & Gurudutta, G.U. (2009) Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. Journal of Cellular and Molecular Medicine, 13, 4385-4402.
37. Schaefer, R., Dominici, M., Muller, I., Horwitz, E., Asahara, T., Bulte, J.W., Bieback, K., Le Blanc, K., Buhring, H.J., Capogrossi, M.C., Dazzi, F., Gorodetsky, R., Henschler, R., Handgretinger, R., Kajstura, J., Kluger, P.J., Lange, C., Luettichau, I., Mertsching, H., Schrezenmeier, H., Sievert, K.D., Strunk, D., Verfaillie, C. & Northoff, H. (2009) Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. Cytotherapy, 11, 245-255.
38. Shayakul, C. & Hediger, M.A. (2004) The SLC14 gene family of urea transporters. Pflugers Archiv, 447, 603-609.
39. Siegel, G., Schafer, R. & Dazzi, F. (2009) The immunosuppressive properties of mesenchymal stem cells. Transplantation, 87, S45-S49.
40. Sundin, M., Ringden, O., Sundberg, B., Nava, S., Gotherstrom, C. & Le Blanc, K. (2007) No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica, 92, 1208-1215.
41. Swardson-Olver, C.J., Dawson, T.C., Burnett, R.C., Peiper, S.C., Maeda, N. & Avery, A.C. (2002) Plasmodium yoelii uses the murine Duffy antigen receptor for chemokines as a receptor for normocyte invasion and an alternative receptor for reticulocyte invasion. Blood, 99, 2677-2684.
42. Terasaki, P.I. & Cai, J. (2008) Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation, 86, 377-383.
43. Tobian, A.A., Shirey, R.S., Montgomery, R.A., Ness, P.M. & King, K.E. (2008) The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion, 48, 2453-2460.
44. Turnovcova, K., Ruzickova, K., Vanecek, V., Sykova, E. & Jendelova, P. (2009) Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy, 11, 874-885.
45. Uccelli, A., Zappia, E., Benvenuto, F., Frassoni, F. & Mancardi, G. (2006) Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Expert Opinion on Biological Therapy, 6, 17-22.
46. Wester, E.S., Johnson, S.T., Copeland, T., Malde, R., Lee, E., Storry, J.R. & Olsson, M.L. (2008) Erythroid urea transporter deficiency due to novel JKnull alleles. Transfusion, 48, 365-372.
47. Wu, L., Cai, X., Dong, H., Jing, W., Huang, Y., Yang, X., Wu, Y. & Lin, Y. (2010) Serum regulates adipogenesis of mesenchymal stem cells via MEK/ERK-dependent PPARgamma expression and phosphorylation. Journal of Cellular and Molecular Medicine, 14, 922-932.
48. Zidi-Yahiaoui, N., Mouro-Chanteloup, I., D' Ambrosio, A.M., Lopez, C., Gane, P., Le van Kim, C., Cartron, J.P., Colin, Y. & Ripoche, P. (2005) Human Rhesus B and Rhesus C glycoproteins: properties of facilitated ammonium transport in recombinant kidney cells. Biochemical Journal, 391, 33-40.